Risk of coronavirus disease 2019 (COVID-19) infection on leukemia patients: basic science to clinical aspect
Agung Firmansyah Sumantri, Muhammad Hasan Bashari, Hilman Tadjoedin, Nur Atik
Abstract
In March 2020, the Coronavirus disease 2019 (COVID-19) pandemic was announced by the World Health Organization (WHO). A novel strain of coronavirus, recently named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) created the disease, which showed symptoms similar to SARS. The virus's bond determines its pathogenesis with its host's cell receptors, mainly the A ngiotensin- C onverting E nzyme 2 (ACE2) . It is a factor of the Renin-Angiotensin System (RAS), that holds a vital f
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusVirologyDiseaseLeukemiaMedicinePandemicCoronavirus InfectionsInfectious disease (medical specialty)ImmunologyInternal medicineOutbreakCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 Research